Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients

Bone Marrow Transplantation

Volumn 50, Issue 9, 2015, Pages 1227-1234

  Yew, P Y ^a   Alachkar, H ^a   Yamaguchi, R ^b   Kiyotani, K ^a   Fang, H ^a   Yap, K L ^a   Liu, H T ^a   Wickrema, A ^a   Artz, A ^a   Van Besien, K ^a,c   Imoto, S ^b   Miyano, S ^b   Bishop, M R ^a   Stock, W ^a   Nakamura, Y ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA; T LYMPHOCYTE RECEPTOR BETA; UNCLASSIFIED DRUG; COMPLEMENTARITY DETERMINING REGION; LYMPHOCYTE ANTIGEN RECEPTOR;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CELL EXPANSION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLONAL VARIATION; COMPLEMENTARITY DETERMINING REGION; COMPLEMENTARITY DETERMINING REGION 3; CONVALESCENCE; GENETIC VARIABILITY; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HISTOCOMPATIBILITY; HLA MATCHING; HUMAN; HUMAN CELL; LEUKEMIA RELAPSE; LYMPHOCYTE FUNCTION; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEQUENCE ANALYSIS; T CELL DEPLETION; T LYMPHOCYTE REPERTOIRE; TCR ALPHA GENE; TCR BETA GENE; UMBILICAL CORD BLOOD; VDJ RECOMBINATION; ALLOGRAFT; CLINICAL TRIAL; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; T LYMPHOCYTE;

ADULT; AGED; ALLOGRAFTS; COMPLEMENTARITY DETERMINING REGIONS; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES;

EID: 84940888696     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2015.133     Document Type: Article

References (34)

1. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med 2006; 354: 1813-1826.
2. van Besien K. Allogeneic transplantation for AML and MDS: GVL versus GVHD and disease recurrence. Hematology Am Soc Hematol Educ Program 2013; 2013: 56-62.
3. Gustafsson Jernberg A, Remberger M, Ringdén O, Winiarski J. Graft-versusleukaemia effect in children: chronic GVHD has a significant impact on relapse and survival. Bone Marrow Transplant 2003; 31: 175-181.
4. Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet 2009; 373: 1550-1561.
5. Shlomchik WD. Graft-versus-host-disease. Nat Rev Immunol 2007; 7: 340-352.
6. Ichiki Y, Bowlus CL, Shimoda S, Ishibashi H, Vierling JM, Gershwin ME. T cell immunity and graft versus host disease (GVHD). Autoimmun Rev 2006; 5: 1-9.
7. Schmaltz C, Alpdogan O, Muriglan SJ, Kappel BJ, Rotolo JA, Ricchetti ET et al. Donor T cell-derived TNF is required for graft versus host disease and graft versus tumor activity after bone marrow transplantation. Blood 2003; 101: 2440-2445.
8. Kataoka Y, Iwasaki T, Kuroiwa T, Seto Y, Iwata N, Hashimoto N et al. The role of donor T cells for target organ injuries in acute and chronic graft versus host disease. Immunology 2001; 103: 310-318.
9. Dong S, Maiella S, Xhaard A, Pang Y, Wenandy L, Larghero J et al. Multiparameter single-cell profiling of human CD4+FOXP3+ regulatory T-cell populations in homeostatic conditions and during graft-versus-host disease. Blood 2013; 122: 1802-1812.
10. Rezvani K, Mielke S, Ahmadzadeh M, Kilical Y, Savani BN, Zeilah J et al. High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood 2006; 108: 1291-1297.
11. Janeway CA, Travers P, Walport M, Shlomchik MJ. Immunobiology: The Immune System in Health and Disease5th edition2005. Glossary, Garland Science, New York.
12. Scaviner D, Lefranc M-P. The human T cell receptor alpha variable (TRAV) genes. Exp Clin Immunogenet 2000; 17: 83-96.
13. Folch G, Lefranc M-P. The human T cell receptor beta variable (TRBV) genes. Exp Clin Immunogenet 2000; 17: 42-54.
14. Meier J, Roberts C, Avent K, Hazlett A, Berrie J, Payne K et al. Fractal organization of the human T cell repertoire in health and after stem cell transplantation. Biol Blood Marrow Transplant 2013; 19: 366-377.
15. Chapman M, Warren EH, Wu CJ. Applications of next-generation sequencing to blood and marrow transplantation. Biol Blood Marrow Transplant 2012; 18(Suppl 1): S151-S160.
16. Woodsworth DJ, Castellarin M, Holt RA. Sequence analysis of T-cell repertoires in health and disease. Genome Med 2013; 5: 98.
17. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825-828.
18. Fang H, Yamaguchi R, Liu X, Daigo Y, Yew PY, Tanikawa C et al. Quantitative T cell repertoire analysis by deep cDNA sequencing of T cell receptor ? and ? chains using next-generation sequencing (NGS). Oncoimmunology 2015; 3: e968467.
19. Giudicelli V, Denys C, Lefranc M-P. IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes. Nucleic Acids Res 2005; 33: D256-D261.
20. Lefranc MP, Clement O, Kaas Q, Duprat E, Chastellan P, Coelho I et al. IMGT, the International ImMunoGeneTics Information System. Nucleic Acids Res 2005; 33: D593-D597.
21. Langmead B, Steven LS. Fast gapped-read alignment with Bowtie 2. Nat Methods 2012; 9: 357-359.
22. Gale RP, Horowitz MM, Ash RC, Champlin RE, Goldman JM, Rimm AA et al. Identical-twin bone marrow transplants for leukemia. Ann Intern Med 1994; 120: 646-652.
23. Hashem H, Lazarus HM. Double umbilical cord blood transplantation: relevance of persistent mixed-unit chimerism. Biol Blood Marrow Transplant 2015; 21: 612-619.
24. Kanda J, Chiou LW, Szabolcs P, Sempowski GD, Rizzieri DA, Long GD et al. Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation. Biol Blood Marrow Transplant 2012; 18: 1664-1676.
25. Liu P, Liu D, Yang X, Gao J, Chen Y, Xiao X et al. Characterization of human TCR repertoire and discovery of D-D fusion in TCR? chains. Protein Cell 2014; 5: 603-615.
26. Kwon M, Balsalobre P, Serrano D, Perez Corral A, Buño I, Anguita J et al. Single cord blood combined with HLA-mismatched third party donor cells: comparable results to matched unrelated donor transplantation in high-risk patients with hematologic disorders. Biol Blood Marrow Transplant 2013; 19: 143-149.
27. van Heijst JW, Ceberio I, Lipuma LB, Samilo DW, Wasilewski GD, Gonzales AM et al. Quantitative assessment of T cell repertoire recovery after hematopoietic stem cell transplantation. Nat Med 2013; 19: 372-377.
28. Liu C, He M, Rooney B, Kepler TB, Chao NJ. Longitudinal analysis of T-cell receptor variable beta chain repertoire in patients with acute graft-versus-host disease after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2006; 12: 335-345.
29. Du JW, Gu JY, Liu J, Cen XN, Zhang Y, Ou Y et al. TCR spectratyping revealed T lymphocytes associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Leuk Lymphoma 2007; 48: 1618-1627.
30. Barrett AJ, Battiwalla M. Relapse after allogeneic stem cell transplantation. Expert Rev Hematol 2010; 3: 429-441.
31. Roomp K, Domingues FS. Predicting interactions between T cell receptors and MHC-peptide complexes. Mol Immunol 2011; 48: 553-562.
32. Ding YH, Smith KJ, Garboczi DN, Utz U, Biddison WE, Wiley DC. Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids. Immunity 1998; 8: 403-411.
33. Cristina C, David NP, Rafick-Pierre S, Francois D. Highly Biased CDR3 Usage in Restricted Sets of ? Chain Variable Regions During Viral Superantigen 9 Response. J Exp Med 1998; 187: 253-258.
34. Davis-Harrison RL, Armstrong KM, Baker BM. Two different T cell receptors use different thermodynamic strategies to recognize the same peptide/MHC ligand. J Mol Biol 2005; 346: 533-550.